Sabra Health Care REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sabra Health Care REIT, Inc. (SBRA) on June 30, 2025. The report details a material corporate event regarding the redemption of outstanding senior notes by the Company's subsidiary, Sabra Health Care Limited Partnership.
Key Financial Metrics and Debt Activity
- Debt Redemption: The Company announced the full redemption of $500 million aggregate principal amount of its 5.125% Senior Notes due 2026.
- Redemption Date: July 31, 2025.
- Redemption Price: 100% of the principal amount plus accrued and unpaid interest and a Make-Whole Amount.
- Funding Source: The redemption is intended to be funded by the issuance of a new $500 million term loan.
- Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, or overall liquidity positions outside of this specific debt transaction.
Material Changes
The primary material change is the refinancing of existing debt. Upon the Redemption Date, the 5.125% Senior Notes will cease to be outstanding, and interest accrual on these notes will stop. This action replaces the existing notes with a new term loan facility of equivalent principal size.
Outlook and Management Commentary
Management has executed a notice of redemption sent by the indenture trustee to all registered holders. The filing does not contain forward-looking guidance, risk factors, or commentary on future operational performance beyond the mechanics of this specific debt transaction.
Investor Verification Checklist
- Verify the final calculation of the Make-Whole Amount to determine the total cash outflow for the redemption.
- Review the terms of the new $500 million term loan, including interest rate, maturity, and covenants, to assess the impact on future interest expense.
- Confirm the net impact on the Company's leverage ratios and liquidity following the swap of the Senior Notes for the term loan.